Latest Delcath Systems News & Updates

See the latest news and media coverage for Delcath Systems. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Delcath Systems

Interventional oncology company focused on liver cancer treatments

delcath.com
Headquarters
New York, United States
Founded year
1987
Company type
Public company
Number of employees
125–200

Last updated

Latest news about Delcath Systems

In short: Delcath Systems reported robust revenue growth, issued a $100M 2026 guidance, and expanded clinical evidence for its HEPZATO KIT and CHEMOSAT system.

Company announcements

Delcath Systems

Delcath Systems reports Q4 and full year 2025 financial results

Revenue reaches $85.2 million with $2.7 million net income. HEPZATO KIT drives growth; 2026 guidance projects at least $100 million revenue. 28 active centers; 140% procedure volume increase.

Unlock all announcements with a

Media coverage

Yahoo Finance

Delcath (DCTH) Q1 2026 Earnings Transcript

Thank you, and welcome to Delcath Systems First Quarter 2026 Earnings Call. With me on the call are Gerard Michel, Chief Executive Officer; Sandra Pennell...

Yahoo Finance

Delcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Metastatic Breast Cancer at ESMO Breast Cancer 2026

Liver-dominant metastatic breast cancer remains a significant clinical challenge, as progression in the liver can be a major driver of morbidity and may limit the...

Unlock all articles with a

Never miss news about Delcath Systems

Track Delcath Systems and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.